Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Metformin hydrochloride |
Is a |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning by metformin |
Causative agent (attribute) |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental poisoning by metformin |
Causative agent (attribute) |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional poisoning by metformin |
Causative agent (attribute) |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by metformin of undetermined intent |
Causative agent (attribute) |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin adverse reaction |
Causative agent (attribute) |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to metformin (finding) |
Causative agent (attribute) |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Overdose of metformin |
Causative agent (attribute) |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental overdose by metformin (disorder) |
Causative agent (attribute) |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional overdose by metformin |
Causative agent (attribute) |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de metformine d'intention indéterminée |
Causative agent (attribute) |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin- and rosiglitazone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metformin hydrochloride 500 mg and rosiglitazone (as rosiglitazone maleate) 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental poisoning by metformin |
Causative agent (attribute) |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Intentional poisoning by metformin |
Causative agent (attribute) |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing metformin and pioglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing metformin and sitagliptin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing metformin and repaglinide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pioglitazone 30mg + metformin 1g m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pioglitazone 15mg + metformin 1g m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to metformin (finding) |
Causative agent (attribute) |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Empagliflozin- and metformin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing canagliflozin and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Canagliflozin- and metformin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Linagliptin- and metformin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing linagliptin and metformin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin pamoate (substance) |
Is a |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metformin hydrochloride |
Is modification of (attribute) |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Metformin pamoate (substance) |
Is modification of (attribute) |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pioglitazone 30mg + metformin 1g prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pioglitazone 15mg + metformin 1g prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing metformin and rosiglitazone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin- and pioglitazone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glibenclamide and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glibenclamide- and metformin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glipizide and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glipizide- and metformin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing metformin and repaglinide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin- and sitagliptin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only canagliflozin and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only empagliflozin and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only glibenclamide and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glipizide and metformin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin and repaglinide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metformin and rosiglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin and pioglitazone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metformin and sitagliptin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Linagliptin and metformin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only glibenclamide and metformin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Linagliptin and metformin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Canagliflozin and metformin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only glipizide and metformin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metformin and pioglitazone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metformin and repaglinide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin and rosiglitazone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metformin and sitagliptin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing metformin and saxagliptin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin- and saxagliptin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin and saxagliptin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin and saxagliptin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dapagliflozin- and metformin- and saxagliptin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dapagliflozin and metformin and saxagliptin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dapagliflozin and metformin and saxagliptin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dapagliflozin- and metformin- and saxagliptin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metformin and vildagliptin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin- and vildagliptin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only metformin and vildagliptin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin- and vildagliptin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing gliclazide and metformin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only gliclazide and metformin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing gliclazide and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only gliclazide and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing alogliptin and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alogliptin and metformin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing alogliptin and metformin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Alogliptin and metformin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin- and voglibose-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only metformin and voglibose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing metformin and voglibose in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Metformin and voglibose only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only empagliflozin and metformin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing dapagliflozin and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing dapagliflozin and metformin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dapagliflozin and metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dapagliflozin and metformin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Metformin therapy (procedure) |
Direct substance |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Empagliflozin- and metformin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metformin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |